|
- Phathom Pharmaceuticals – Leading the way to innovative treatments for . . .
Phathom Pharmaceuticals is a biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid-related gastrointestinal (GI) disorders
- Phathom Pharmaceuticals, Inc. (PHAT) - Yahoo Finance
Find the latest Phathom Pharmaceuticals, Inc (PHAT) stock quote, history, news and other vital information to help you with your stock trading and investing
- Phathom Pharmaceuticals (PHAT) Stock Price, News Analysis
Phathom Pharmaceuticals is a clinical‐stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases
- Assessing Phathom Pharmaceuticals (PHAT) Valuation After Bullish Rating . . .
Phathom Pharmaceuticals stock reacts to upbeat earnings and new trial progress Phathom Pharmaceuticals (PHAT) grabbed investor attention after a bullish new analyst rating landed alongside quarterly results that beat forecasts, a raised 2025 revenue outlook, and fresh clinical progress for VOQUEZNA See our latest analysis for Phathom Pharmaceuticals Those upbeat earnings, stronger VOQUEZNA
- Phathom Pharmaceuticals stock hits 52-week high at $16. 27
Phathom Pharmaceuticals Inc (PHAT) reached a 52-week high, with its stock price climbing to $16 27 This milestone reflects a significant turnaround for the company, which has seen its stock
- Why Phathom Pharmaceuticals, Inc. ’s (PHAT) Stock Is Up 6. 51%
As of Thursday, December 18, Phathom Pharmaceuticals, Inc ’s PHAT share price has surged by 6 51%, which has investors questioning if this is right time to sell
- Assessing Phathom Pharmaceuticals (PHAT) Valuation After Bullish Rating . . .
Phathom Pharmaceuticals stock reacts to upbeat earnings and new trial progress Phathom Pharmaceuticals (PHAT) grabbed investor attention after a bullish new analyst rating landed alongside quarterly results that beat forecasts, a raised 2025 revenue outlook, and fresh clinical progress for VOQUEZNA
- Phathom Pharmaceuticals Announces Positive FDA Decision to
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases
|
|
|